An Effective Method to Identify Cooperation Driver Gene Sets

被引:0
作者
Zhang, Wei [1 ]
Zeng, Yifu [1 ]
Zhao, Bihai [1 ]
Xiong, Jie [2 ]
Zhu, Tuanfei [1 ]
Wang, Jingjing [1 ]
Li, Guiji [1 ]
Wang, Lei [1 ]
机构
[1] Changsha Univ, Coll Comp Sci & Engn, Changsha 410022, Hunan, Peoples R China
[2] Changsha Univ, Coll Math, Dept Informat & Comp Sci, Changsha 410003, Peoples R China
基金
中国国家自然科学基金;
关键词
Cancer progression; binary gene mutation matrix; driver gene; co-occurrence mutations; coordinated regulation; stratify patients; MUTUAL EXCLUSIVITY; PATHWAYS; CANCER; ALGORITHMS; MUTATIONS;
D O I
10.2174/0115748936293238240313081211
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background In cancer genomics research, identifying driver genes is a challenging task. Detecting cancer-driver genes can further our understanding of cancer risk factors and promote the development of personalized treatments. Gene mutations show mutual exclusivity and co-occur, and most of the existing methods focus on identifying driver pathways or driver gene sets through the study of mutual exclusivity, that is functionally redundant gene sets. Moreover, less research on cooperation genes with co-occurring mutations has been conducted.Objective We propose an effective method that combines the two characteristics of genes, co-occurring mutations and the coordinated regulation of proliferation genes, to explore cooperation driver genes.Methods This study is divided into three stages: (1) constructing a binary gene mutation matrix; (2) combining mutation co-occurrence characteristics to identify the candidate cooperation gene sets; and (3) constructing a gene regulation network to screen the cooperation gene sets that perform synergistically regulating proliferation.Results The method performance is evaluated on three TCGA cancer datasets, and the experiments showed that it can detect effective cooperation driver gene sets. In further investigations, it was determined that the discovered set of co-driver genes could be used to generate prognostic classifications, which could be biologically significant and provide complementary information to the cancer genome.Conclusion Our approach is effective in identifying sets of cancer cooperation driver genes, and the results can be used as clinical markers to stratify patients.
引用
收藏
页码:59 / 69
页数:11
相关论文
共 42 条
  • [1] Alhasani AT, 2023, Methods, V7, DOI [10.54216/JAIM.040201, DOI 10.54216/JAIM.040201]
  • [2] Glioblastoma multiforme: Pathogenesis and treatment
    Alifieris, Constantinos
    Trafalis, Dimitrios T.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2015, 152 : 63 - 82
  • [3] Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations
    Babur, Ozgun
    Gonen, Mithat
    Aksoy, Bulent Arman
    Schultz, Nikolaus
    Ciriello, Giovanni
    Sander, Chris
    Demir, Emek
    [J]. GENOME BIOLOGY, 2015, 16
  • [4] Global challenges in breast cancer detection and treatment
    Barrios, Carlos H.
    [J]. BREAST, 2022, 62 : S3 - S6
  • [5] BEROUKHIM R, 2007, P NATL ACAD SCI USA, V104
  • [6] Efficient algorithms for influence maximization in social networks
    Chen, Yi-Cheng
    Peng, Wen-Chih
    Lee, Suh-Yin
    [J]. KNOWLEDGE AND INFORMATION SYSTEMS, 2012, 33 (03) : 577 - 601
  • [7] Mutual exclusivity analysis identifies oncogenic network modules
    Ciriello, Giovanni
    Cerami, Ethan
    Sander, Chris
    Schultz, Nikolaus
    [J]. GENOME RESEARCH, 2012, 22 (02) : 398 - 406
  • [8] BeWith: A Between-Within method to discover relationships between cancer modules via integrated analysis of mutual exclusivity, co-occurrence and functional interactions
    Dao, Phuong
    Kim, Yoo-Ah
    Wojtowicz, Damian
    Madan, Sanna
    Sharan, Roded
    Przytycka, Teresa M.
    [J]. PLOS COMPUTATIONAL BIOLOGY, 2017, 13 (10)
  • [9] Breast cancer detection using deep learning: Datasets, methods, and challenges ahead
    Din, Nusrat Mohi ud
    Dar, Rayees Ahmad
    Rasool, Muzafar
    Assad, Assif
    [J]. COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 149
  • [10] Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo
    Elsum, I. A.
    Yates, L. L.
    Pearson, H. B.
    Phesse, T. J.
    Long, F.
    O'Donoghue, R.
    Ernst, M.
    Cullinane, C.
    Humbert, P. O.
    [J]. ONCOGENE, 2014, 33 (48) : 5523 - 5533